Van Well Daan
Known title: Chief Legal OfficerCIK: 0002006414
Associated companies
Transaction History
| SOPH | ▼ Sell | Open Market | 6,168 | $47K | 9/11/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 684 | $3K | 5/19/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 684 | $4K | 4/20/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 2,400 | $11K | 4/10/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 1,988 | $9K | 4/9/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 2,861 | $14K | 4/8/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 2,400 | $12K | 4/7/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 2,705 | $13K | 4/6/2026 | View on chart |
| SOPH | ▲ Buy | Grant | 97,536 | $0 | 4/2/2026 | View on chart |
| SOPH | ▼ Sell | Open Market | 684 | $3K | 3/19/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
SOPHiA GENETICS Shares Rise 7% Amid Questions on Momentum
Shares of SOPHiA GENETICS climbed 7% in early trading, pushing the stock toward the upper end of its 52‑week range. The move comes with an RSI of 55.5, indicating moderate momentum, and the stock remains above the $4.85 support level that has been tested 13 times. Analysts keep a target of $9.75, but the recent gain raises questions about how long the upward trend can continue.
SOPHiA GENETICS Shares Rise 7% Amid Questions on Momentum. Shares of SOPHiA GENETICS climbed 7% in early trading, pushing the stock toward the upper end of its 52‑week range. The move comes with an RSI of 55.5, indicating moderate momentum, and the stock remains above the $4.85 support level that has been tested 13 times. Analysts keep a target of $9.75, but the recent gain raises questions about how long the upward trend can continue.